Liberty Signs Multi-Year National Strategic Partnership Agreement with the American Diabetes Association

  
    
  
  
    
      PolyMedica Corporation (NASDAQ: PLMD) today announced that its wholly 
      owned subsidiary, Liberty Healthcare Group, Inc. (“Liberty”), 
      the nation's largest mail order diabetes supply company, has entered 
      into a multi-year National Strategic Partnership agreement with the 
      American Diabetes Association (ADA). As a National Strategic Partner, 
      Liberty will support the ADA’s “I 
      Decide To Fight DiabetesSM" campaign.
    
    
      The “I Decide To Fight Diabetes” 
      campaign is focused on inspiring people to live healthier lives and to 
      make better choices when it comes to preventing and managing diabetes. 
      The campaign is focused on raising funds to support the mission of the 
      American Diabetes Association – to prevent and 
      cure diabetes and to improve the lives of all people affected by 
      diabetes as well as to help people express themselves as part of a 
      movement to stem the tide against the disease. People with diabetes, 
      their friends and families, as well as those at risk, are encouraged to 
      display their commitment by wearing an “I 
      Decide To Fight Diabetes” charm, t-shirt, or 
      other item available at the ADA’s web site, www.diabetes.org/IDecide.
    
    
      “By becoming a National Charter Sponsor of 
      the ‘I Decide to Fight Diabetes’ 
      campaign, Liberty is helping to amplify the voice of the diabetes cause,” stated 
      Patrick T. Ryan, Chief Executive Officer of PolyMedica. “Liberty’s 
      team members are proud to support the American Diabetes Association in 
      this critical fight against diabetes.”
    
    
      Liberty will help to further the mission of the ADA and an important 
      Liberty priority by offering support for the “I 
      Decide to Fight Diabetes” campaign, which 
      seeks to inspire and empower patients in leading healthier lives. 
      Liberty patients will benefit from access to the ADA’s 
      resources.
    
    
      “The ADA needs more champions in the fight 
      against diabetes, and we appreciate Liberty’s 
      commitment to people living with diabetes and their support of the ADA’s 
      mission,” said Larry C. Deeb, MD, ADA’s 
      President, Medicine & Science.
    
    
      Today, diabetes is America’s number one 
      health threat:
    
    
      
        Nearly 21 million adults and children have diabetes
      
      
        One-third of them (6.2 million) don't know they have the disease
      
      
        One in three Americans born in 2000 will develop diabetes in their 
        lifetime if nothing is done to stem the tide
      
      
        Diabetes kills more people than breast cancer and AIDS combined
      
    
    
      For more information on Liberty, go to www.libertymedical.com. 
      For more information on the American Diabetes Association and the “I 
      Decide To Fight Diabetes” campaign, go to www.diabetes.org/IDecide.
    
    
      About PolyMedica Corporation and Liberty 
      Healthcare Group
    
    
      For more than a decade, Liberty has been the nation’s 
      largest provider of blood glucose testing supplies and related services 
      to people with diabetes and today serves more than 943,000 active 
      diabetes patients. Liberty also offers a full service pharmacy to meet 
      patients’ medication needs and provides 
      patient education to help its patients better manage their health 
      conditions. Through proactive patient outreach, convenient home delivery 
      and administrative support, Liberty makes it simple for patients to 
      obtain the supplies and medications they need, while encouraging 
      compliance with physicians’ orders. More 
      information about Liberty and PolyMedica Corporation can be found at www.libertymedical.com 
      and www.polymedica.com.
    
    
      About ADA
    
    
      The American Diabetes Association is the nation’s 
      premier voluntary health organization supporting diabetes research, 
      information and advocacy. Founded in 1940, the Association has offices 
      in every region providing services to hundreds of communities. Its 
      mission is to prevent and cure diabetes and approve the lives of all 
      people affected by diabetes. For more information, please visit www.diabetes.org 
      or call 1-800-DIABETES (1-800-342-2382). Information from both these 
      sources is available in English and Spanish.
    
    
      This press release contains forward-looking statements as that term 
      is defined in the Private Securities Litigation Reform Act of 1995. Such 
      forward-looking statements are subject to risks and uncertainties, which 
      could cause actual results to differ materially from those anticipated. 
      Such risks and uncertainties include, but are not limited to, rules 
      and regulations promulgated under the Act, unanticipated changes in 
      Medicare reimbursement, successful participation in new reimbursement 
      programs, outcomes of government reviews, inquiries, investigations and 
      related litigation, continued compliance with government regulations, 
      fluctuations in customer demand, management of rapid growth, competition 
      from other healthcare product vendors, timing and acceptance of new 
      product introductions, general economic conditions, geopolitical events 
      and regulatory changes, as well as other especially relevant risks 
      detailed in PolyMedica’s filings with the 
      Securities and Exchange Commission, including its Annual Report on Form 
      10-K for the period ended March 31, 2007, and Quarterly Reports on Form 
      10-Q for the periods ended June 30, 2006, September 30, 2006 and 
      December 31, 2006. The information set forth herein should be 
      read in light of such risks. PolyMedica assumes no obligation to 
      update the information contained in this press release.